Impax Transferring Products To Taiwan After GMP Warning Letter For U.S. Plant

Future applications involving the Hayward, Calif. plant targeted by warning letter on manufacturing practices may be stalled, but Phase III Parkinson's candidate IPX066 won't be affected, execs say.

More from Archive

More from Pink Sheet